Actualités
Article du mois de Juillet
Article du mois de Juin
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
May 31, 2015DOI: 10.1056/NEJMoa1504627
Article du mois d’Avril
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
Ben J Slotman, Harm van Tinteren, John O Praag, Joost L Knegjens, Sherif Y El Sharouni, Matthew Hatton, Astrid Keijser, Corinne Faivre-Finn*,
Suresh Senan*
Lancet 2015; 385: 36–42*
Article du mois de mars
Article du mois de février
Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014
Morgensztern, Daniel MD*; Campo, Meghan J. MD†; Dahlberg, Suzanne E. PhD‡; Doebele, Robert C. MD, PhD§; Garon, Edward MD‖; Gerber, David E. MD¶; Goldberg, Sarah B. MD#; Hammerman, Peter S. MD, PhD†; Heist, Rebecca S. MD**; Hensing, Thomas MD††; Horn, Leora MD‡‡; Ramalingam, Suresh S. MD§§; Rudin, Charles M. MD, PhD‖‖; Salgia, Ravi MD, PhD††; Sequist, Lecia V. MD**; Shaw, Alice T. MD, PhD**; Simon, George R. MD¶¶; Somaiah, Neeta MD¶¶; Spigel, David R. MD##; Wrangle, John MD***; Johnson, David MD†††; Herbst, Roy S. MD, PhD#; Bunn, Paul MD‡‡‡; Govindan, Ramaswamy MD*
Journal of Thoracic Oncology:
Article du mois de Janvier
Modh A1, Rimner A1, Williams E2, Foster A1, Shah M1, Shi W3, Zhang Z3, Gelblum DY1, Rosenzweig KE4, Yorke ED2, Jackson A2, Wu AJ5.
Article du mois de décembre
Puneeth Iyengar, Brian D. Kavanagh, Zabi Wardak, Irma Smith, Chul Ahn, David E. Gerber, Jonathan Dowell, Randall Hughes, Ramzi Abdulrahman, D. Ross Camidge, Laurie E. Gaspar, Robert C. Doebele, Paul A. Bunn, Hak Choy and Robert Timmerman
Presented in part at American Society of Clinical Oncology Annual Meeting, Chicago, IL, May 31-June 4, 2013.
Article du mois de Novembre
Novel agents in development for advanced non-small cell lung cancer.
Ther Adv Med Oncol. 2014 Sep;6(5):240-53. doi: 10.1177/1758834014532510.
Article du mois d’Octobre
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.